Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2018

Open Access 01-12-2018 | Case Report

Intracystic papillary carcinoma of the male breast: a case report

Authors: Haruhito Kinoshita, Shinichiro Kashiwagi, Hitoshi Teraoka, Takuya Mori, Kenji Kuroda, Mikio Nanbara, Eiji Noda, Takaaki Chikugo, Kosei Hirakawa, Masaichi Ohira

Published in: World Journal of Surgical Oncology | Issue 1/2018

Login to get access

Abstract

Background

Intracystic papillary carcinoma (IPC) is defined as cancer that develops from the wall of a cyst in the breast. As breast cancer in men accounts for only 1% of all breast cancers, male IPC is an extremely rare form of the disease. The present case report examines IPC in a man, along with an in-depth literature discussion.

Case presentation

A 64-year-old Japanese man noticed a mass in the right breast and sought medical attention. An elastic and soft neoplastic 3-cm lesion was palpated in the right papilla. As a 1-cm solid tumor with a gradual rise from the cyst wall was confirmed within the cyst, vacuum-assisted biopsy (VAB) was performed on that site. Pathological examination of the biopsy revealed heterotypic cells with an enlarged oval nucleus forming dense papillary structures mainly of vascular connective tissue component. Contrast-enhanced computed tomography (CT) confirmed thickening of the wall that protruded outside the cyst. The preoperative diagnosis was right breast cancer (male IPC) TisN0M0 stage 0 luminal B-like. Total mastectomy and sentinel lymph node biopsy were performed. In the excised specimen, a 4.0-cm unilocular cyst was found, along with a 1-cm solid tumor with a gradual rise from the cyst wall. Pathological diagnosis of the resected specimen shared similar characteristics with the solid tumor in the cyst: notably, an oval nucleus with histologically clear nucleolus and fine granular chromatin, cylindrically shaped heterotypic cells, and the presence of basophilic cells in the papillary growth with a thin stem of fibrovasculature as the axis. Some invasion of tumor cells into the interstitium was confirmed. As such, the final diagnosis was right breast cancer (male IPC) T2N0M0 stage IIA luminal B-like. The expression of hormone receptor (ER and PgR) was high, and endocrine therapy was initiated postoperatively (20 mg/day tamoxifen). At the present time (3 months postoperation), there has not been any evidence of metastasis.

Conclusions

We reported a rare case of an IPC in the male breast, along with a literature review.
Literature
1.
go back to reference Czernobilsky B. Intracystic carcinoma of the female breast. Surg Gynecol Obstet. 1967;124(1):93–8.PubMed Czernobilsky B. Intracystic carcinoma of the female breast. Surg Gynecol Obstet. 1967;124(1):93–8.PubMed
2.
3.
go back to reference Romics L Jr, O'Brien ME, Relihan N, O'Connell F, Redmond HP. Intracystic papillary carcinoma in a male as a rare presentation of breast cancer: a case report and literature review. J Med Case Rep. 2009;3:13.CrossRefPubMedPubMedCentral Romics L Jr, O'Brien ME, Relihan N, O'Connell F, Redmond HP. Intracystic papillary carcinoma in a male as a rare presentation of breast cancer: a case report and literature review. J Med Case Rep. 2009;3:13.CrossRefPubMedPubMedCentral
4.
go back to reference Tochika N, Takano A, Yoshimoto T, Tanaka J, Sugimoto T, Kobayashi M, Matsuura K, Araki K, Ogawa Y, Moriki T. Intracystic carcinoma of the male breast: report of a case. Surg Today. 2001;31(9):806–9.CrossRefPubMed Tochika N, Takano A, Yoshimoto T, Tanaka J, Sugimoto T, Kobayashi M, Matsuura K, Araki K, Ogawa Y, Moriki T. Intracystic carcinoma of the male breast: report of a case. Surg Today. 2001;31(9):806–9.CrossRefPubMed
5.
6.
go back to reference Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol. 2006;30(8):1002–7.CrossRefPubMed Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol. 2006;30(8):1002–7.CrossRefPubMed
7.
go back to reference Solorzano CC, Middleton LP, Hunt KK, Mirza N, Meric F, Kuerer HM, Ross MI, Ames FC, Feig BW, Pollock RE, et al. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg. 2002;184(4):364–8.CrossRefPubMed Solorzano CC, Middleton LP, Hunt KK, Mirza N, Meric F, Kuerer HM, Ross MI, Ames FC, Feig BW, Pollock RE, et al. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg. 2002;184(4):364–8.CrossRefPubMed
8.
go back to reference Levine PH, Waisman J, Yang GC. Aspiration cytology of cystic carcinoma of the breast. Diagn Cytopathol. 2003;28(1):39–44.CrossRefPubMed Levine PH, Waisman J, Yang GC. Aspiration cytology of cystic carcinoma of the breast. Diagn Cytopathol. 2003;28(1):39–44.CrossRefPubMed
9.
go back to reference Imoto S, Hasebe T. Intracystic papillary carcinoma of the breast in male: case report and review of the Japanese literature. Jpn J Clin Oncol. 1998;28(8):517–20.CrossRefPubMed Imoto S, Hasebe T. Intracystic papillary carcinoma of the breast in male: case report and review of the Japanese literature. Jpn J Clin Oncol. 1998;28(8):517–20.CrossRefPubMed
11.
go back to reference Carter D, Orr SL, Merino MJ. Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer. 1983;52(1):14–9.CrossRefPubMed Carter D, Orr SL, Merino MJ. Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer. 1983;52(1):14–9.CrossRefPubMed
13.
go back to reference Fayanju OM, Ritter J, Gillanders WE, Eberlein TJ, Dietz JR, Aft R, Margenthaler JA. Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. Am J Surg. 2007;194(4):497–500.CrossRefPubMed Fayanju OM, Ritter J, Gillanders WE, Eberlein TJ, Dietz JR, Aft R, Margenthaler JA. Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. Am J Surg. 2007;194(4):497–500.CrossRefPubMed
14.
go back to reference Khan MH, Allerton R, Pettit L. Hormone therapy for breast cancer in men. Clin Breast Cancer. 2015;15(4):245–50.CrossRefPubMed Khan MH, Allerton R, Pettit L. Hormone therapy for breast cancer in men. Clin Breast Cancer. 2015;15(4):245–50.CrossRefPubMed
15.
go back to reference Javidiparsijani S, Rosen LE, Gattuso P: Male breast carcinoma: a clinical and pathological review. Int J Surg Pathol. 2017;25(3):200–5. Javidiparsijani S, Rosen LE, Gattuso P: Male breast carcinoma: a clinical and pathological review. Int J Surg Pathol. 2017;25(3):200–5.
16.
go back to reference Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist. 2005;10(7):471–9.CrossRefPubMed Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist. 2005;10(7):471–9.CrossRefPubMed
18.
go back to reference Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN. Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005;104(11):2359–64.CrossRefPubMed Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN. Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005;104(11):2359–64.CrossRefPubMed
19.
go back to reference Fogh S, Hirsch AE, Langmead JP, Goldberg SI, Rosenberg CL, Taghian AG, Powell SN, Kachnic LA. Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer. 2011;11(1):39–45.CrossRefPubMed Fogh S, Hirsch AE, Langmead JP, Goldberg SI, Rosenberg CL, Taghian AG, Powell SN, Kachnic LA. Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer. 2011;11(1):39–45.CrossRefPubMed
Metadata
Title
Intracystic papillary carcinoma of the male breast: a case report
Authors
Haruhito Kinoshita
Shinichiro Kashiwagi
Hitoshi Teraoka
Takuya Mori
Kenji Kuroda
Mikio Nanbara
Eiji Noda
Takaaki Chikugo
Kosei Hirakawa
Masaichi Ohira
Publication date
01-12-2018
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2018
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-018-1318-5

Other articles of this Issue 1/2018

World Journal of Surgical Oncology 1/2018 Go to the issue